UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Hepatology (Baltimore, Md.), ISSN 0270-9139, 04/2018, Volume 67, Issue 4, pp. 1560 - 1599
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepatitis B, Chronic - drug therapy | Antiviral Agents - therapeutic use | Antiviral Agents - adverse effects | Hepatitis B Vaccines - administration & dosage | Humans | Counseling - methods | Adult | Hepatitis B, Chronic - diagnosis | Child | Mass Screening - methods | Hepatitis B, Chronic - prevention & control | Hepatitis B | Index Medicus
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 01/2018, Volume 47, Issue 1, pp. 43 - 54
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Liver Neoplasms - virology | Hepatitis B Core Antigens - blood | Humans | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B, Chronic - virology | Hepatitis B, Chronic - drug therapy | Biopsy | DNA, Circular | Hepatitis B virus - genetics | Hepatitis B e Antigens - blood | Antigens | Medical research | Immunotherapy | Liver | Medicine, Experimental | Development and progression | Circular DNA | Hepatitis B virus | Health aspects | Hepatitis B | Hepatitis B surface antigen | Invasiveness | Medical treatment | Chronic infection | Viruses | Hepatocellular carcinoma | Infections | Activation | Nuclei | Seroconversion | Immunosuppressive agents | Hepatitis B e antigen | Hepatitis | Reviews | Hepatocytes | Interferon | Monitoring | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2015, Volume 372, Issue 6, pp. 528 - 536
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Brain Ischemia - complications | Neuroprotective Agents - therapeutic use | Acute Disease | Double-Blind Method | Time-to-Treatment | Humans | Middle Aged | Male | Magnesium Sulfate - therapeutic use | Stroke - drug therapy | Magnesium Sulfate - adverse effects | Stroke - etiology | Hemorrhage - etiology | Female | Aged | Infusions, Intravenous | Neuroprotective Agents - adverse effects | Stroke - mortality | Emergency Medical Services | Intracranial Hemorrhages - complications | Stroke (Disease) | Magnesium sulfate | Usage | Care and treatment | Hospitals | Analysis | Outcome and process assessment (Health Care) | Management | Risk factors | Neuroprotection | Medical research | Stroke | Intravenous administration | Clinical trials | Preventive medicine | Neuroprotective agents | Hemorrhage | Mimicry | Neurological diseases | Neurology | Ischemia | Magnesium | Index Medicus | Abridged Index Medicus
Journal Article